Physician profile
Anca Chiriac
NPI 1134448020
$12,767.07
in general payments reported to CMS, 2019-2025
6 companies · $691 in 2025
The $691 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,684 · 2020: $1,277 · 2021: $1,561 · 2022: $4,884 · 2023: $1,120 · 2024: $1,550 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,348 · Food and Beverage: $697 · Education: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,347.52 |
| Food and Beverage | $697.30 |
| Education | $315.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,870.18 | 2021-2024 | Evera Mri Xt Dr Surescan |
| Abbott Laboratories | $3,408.55 | 2019-2025 | Aveir |
| Medical Device Business Services, INC. | $2,573.36 | 2019-2024 | Carto 3 |
| Biosense Webster, INC. | $452.70 | 2021-2025 | Carto 3, Qdot Micro Catheter |
| Boston Scientific Corporation | $348.35 | 2020-2025 | Rhythmia Mapping System |
| Merit Medical Systems INC | $113.93 | 2024 | Worley Adv Coronary Sinus Guide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anca Chiriac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.